Clinical Trials for Encoded Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Encoded Therapeutics

Clinical Trials (4)

NCT05419492
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
PHASE1/PHASE2Recruiting
22 participants
Started: May 14, 2024 · Completed: Apr 30, 2031
1 condition1 sponsor3 locations
NCT06283212
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome
PHASE1/PHASE2Recruiting
4 participants
Started: May 9, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor3 locations
NCT06112275
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children with SCN1A-positive Dravet Syndrome (Australia Only)
PHASE1/PHASE2Recruiting
4 participants
Started: Feb 28, 2024 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT05651204
GABA Biomarkers in Dravet Syndrome
N/ARecruiting
36 participants
Started: Sep 8, 2022 · Completed: Sep 8, 2027
1 condition2 sponsors1 location